- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Natco Pharma Limited — Updates, 20-08-2025: Press Release
20-08-2025 | 10:48 am
20-08-2025 | 10:48 am
NATCO Pharma launched generic Bosentan tablets in the US with 180-day exclusivity. This drug targets pulmonary arterial hypertension. The US market for this product previously saw estimated sales of USD 1 Cr.
No comments yet. Be the first to comment!